AAPL353.43-2.85 (-0.80%) ▼|ABBV296.48+1.45 (+0.49%) ▲|ABT108.39-0.13 (-0.12%) ▼|ACN251.40+0.91 (+0.36%) ▲|ADBE249.07+5.99 (+2.46%) ▲|AMAT352.20-18.30 (-4.94%) ▼|AMD505.08-28.98 (-5.43%) ▼|AMGN466.92+1.25 (+0.27%) ▲|AMT191.03-0.62 (-0.32%) ▼|AMZN258.50-8.16 (-3.06%) ▼|AVGO331.81-15.20 (-4.38%) ▼|AXP318.55-2.05 (-0.64%) ▼|BA166.14-5.36 (-3.13%) ▼|BAC50.06-0.96 (-1.88%) ▼|BKNG156.95-2.63 (-1.65%) ▼|BLK1,199.56-23.36 (-1.91%) ▼|BMY63.33-0.10 (-0.16%) ▼|BNY151.93-1.48 (-0.96%) ▼|BRK-B593.13+0.19 (+0.03%) ▲|C121.28-2.73 (-2.20%) ▼|CAT574.35-25.85 (-4.31%) ▼|CL101.64+1.97 (+1.98%) ▲|CMCSA25.62+0.46 (+1.83%) ▲|COF192.77-1.51 (-0.78%) ▼|COP140.18-1.17 (-0.83%) ▼|COST1,111.47+5.26 (+0.48%) ▲|CRM216.73-1.11 (-0.51%) ▼|CSCO94.69-0.95 (-0.99%) ▼|CVS88.27-1.08 (-1.21%) ▼|CVX217.25-2.64 (-1.20%) ▼|DE660.11-13.43 (-1.99%) ▼|DHR231.93-1.10 (-0.47%) ▼|DIS118.29-0.68 (-0.57%) ▼|DUK130.38+1.22 (+0.94%) ▲|EMR161.01-5.37 (-3.23%) ▼|FDX326.67+2.53 (+0.78%) ▲|GD359.62-3.84 (-1.06%) ▼|GE326.86-4.95 (-1.49%) ▼|GEV762.96-40.17 (-5.00%) ▼|GILD169.22+1.14 (+0.68%) ▲|GM83.82-2.18 (-2.53%) ▼|GOOG283.67-8.85 (-3.03%) ▼|GOOGL286.53-9.24 (-3.12%) ▼|GS889.70-26.86 (-2.93%) ▼|HD348.19-0.50 (-0.14%) ▼|HON220.06-2.41 (-1.08%) ▼|IBM244.32-2.81 (-1.14%) ▼|INTC55.26-4.41 (-7.38%) ▼|INTU348.99+7.29 (+2.13%) ▲|ISRG441.79-1.80 (-0.41%) ▼|JNJ284.93-0.82 (-0.29%) ▼|JPM338.92-7.27 (-2.10%) ▼|KO99.46+0.21 (+0.21%) ▲|LIN526.32+0.26 (+0.05%) ▲|LLY1,443.31-0.19 (-0.01%) ▼|LMT582.92-13.12 (-2.20%) ▼|LOW226.69-1.05 (-0.46%) ▼|LRCX210.88-15.04 (-6.66%) ▼|MA664.41+3.22 (+0.49%) ▲|MCD276.35+4.38 (+1.61%) ▲|MDLZ68.06+0.52 (+0.76%) ▲|MDT103.30+0.44 (+0.42%) ▲|META624.89-16.80 (-2.62%) ▼|MMM183.26-0.40 (-0.22%) ▼|MO78.81+0.17 (+0.22%) ▲|MRK146.37-1.39 (-0.94%) ▼|MS184.21-6.44 (-3.38%) ▼|MSFT521.11-2.77 (-0.53%) ▼|MU722.39-55.92 (-7.19%) ▼|NEE85.54+0.42 (+0.49%) ▲|NFLX60.87-1.28 (-2.06%) ▼|NKE37.82-0.17 (-0.45%) ▼|NOW100.53-1.72 (-1.69%) ▼|NVDA155.25-7.60 (-4.67%) ▼|ORCL118.96-6.39 (-5.10%) ▼|PEP147.69+2.25 (+1.55%) ▲|PFE28.95+0.06 (+0.19%) ▲|PG173.13+3.33 (+1.96%) ▲|PLTR161.10-6.89 (-4.10%) ▼|PM196.43-2.53 (-1.27%) ▼|QCOM170.86-1.61 (-0.93%) ▼|RTX195.70-2.88 (-1.45%) ▼|SBUX108.04+1.60 (+1.50%) ▲|SCHW93.34+0.36 (+0.38%) ▲|SO94.08+1.25 (+1.35%) ▲|SPG231.12-1.85 (-0.79%) ▼|T22.31+0.13 (+0.56%) ▲|TMO695.19-5.03 (-0.72%) ▼|TMUS171.88+1.93 (+1.14%) ▲|TSLA378.61-11.62 (-2.98%) ▼|TXN295.91-7.70 (-2.53%) ▼|UBER69.67-0.02 (-0.03%) ▼|UNH410.10+2.64 (+0.65%) ▲|UNP304.43+1.99 (+0.66%) ▲|UPS111.29+0.53 (+0.48%) ▲|USB60.44-0.55 (-0.90%) ▼|V427.39+1.63 (+0.38%) ▲|VZ46.43+0.07 (+0.15%) ▲|WFC84.38-1.68 (-1.95%) ▼|WMT128.25+0.16 (+0.12%) ▲|XOM167.38-2.14 (-1.26%) ▼|AAPL353.43-2.85 (-0.80%) ▼|ABBV296.48+1.45 (+0.49%) ▲|ABT108.39-0.13 (-0.12%) ▼|ACN251.40+0.91 (+0.36%) ▲|ADBE249.07+5.99 (+2.46%) ▲|AMAT352.20-18.30 (-4.94%) ▼|AMD505.08-28.98 (-5.43%) ▼|AMGN466.92+1.25 (+0.27%) ▲|AMT191.03-0.62 (-0.32%) ▼|AMZN258.50-8.16 (-3.06%) ▼|AVGO331.81-15.20 (-4.38%) ▼|AXP318.55-2.05 (-0.64%) ▼|BA166.14-5.36 (-3.13%) ▼|BAC50.06-0.96 (-1.88%) ▼|BKNG156.95-2.63 (-1.65%) ▼|BLK1,199.56-23.36 (-1.91%) ▼|BMY63.33-0.10 (-0.16%) ▼|BNY151.93-1.48 (-0.96%) ▼|BRK-B593.13+0.19 (+0.03%) ▲|C121.28-2.73 (-2.20%) ▼|CAT574.35-25.85 (-4.31%) ▼|CL101.64+1.97 (+1.98%) ▲|CMCSA25.62+0.46 (+1.83%) ▲|COF192.77-1.51 (-0.78%) ▼|COP140.18-1.17 (-0.83%) ▼|COST1,111.47+5.26 (+0.48%) ▲|CRM216.73-1.11 (-0.51%) ▼|CSCO94.69-0.95 (-0.99%) ▼|CVS88.27-1.08 (-1.21%) ▼|CVX217.25-2.64 (-1.20%) ▼|DE660.11-13.43 (-1.99%) ▼|DHR231.93-1.10 (-0.47%) ▼|DIS118.29-0.68 (-0.57%) ▼|DUK130.38+1.22 (+0.94%) ▲|EMR161.01-5.37 (-3.23%) ▼|FDX326.67+2.53 (+0.78%) ▲|GD359.62-3.84 (-1.06%) ▼|GE326.86-4.95 (-1.49%) ▼|GEV762.96-40.17 (-5.00%) ▼|GILD169.22+1.14 (+0.68%) ▲|GM83.82-2.18 (-2.53%) ▼|GOOG283.67-8.85 (-3.03%) ▼|GOOGL286.53-9.24 (-3.12%) ▼|GS889.70-26.86 (-2.93%) ▼|HD348.19-0.50 (-0.14%) ▼|HON220.06-2.41 (-1.08%) ▼|IBM244.32-2.81 (-1.14%) ▼|INTC55.26-4.41 (-7.38%) ▼|INTU348.99+7.29 (+2.13%) ▲|ISRG441.79-1.80 (-0.41%) ▼|JNJ284.93-0.82 (-0.29%) ▼|JPM338.92-7.27 (-2.10%) ▼|KO99.46+0.21 (+0.21%) ▲|LIN526.32+0.26 (+0.05%) ▲|LLY1,443.31-0.19 (-0.01%) ▼|LMT582.92-13.12 (-2.20%) ▼|LOW226.69-1.05 (-0.46%) ▼|LRCX210.88-15.04 (-6.66%) ▼|MA664.41+3.22 (+0.49%) ▲|MCD276.35+4.38 (+1.61%) ▲|MDLZ68.06+0.52 (+0.76%) ▲|MDT103.30+0.44 (+0.42%) ▲|META624.89-16.80 (-2.62%) ▼|MMM183.26-0.40 (-0.22%) ▼|MO78.81+0.17 (+0.22%) ▲|MRK146.37-1.39 (-0.94%) ▼|MS184.21-6.44 (-3.38%) ▼|MSFT521.11-2.77 (-0.53%) ▼|MU722.39-55.92 (-7.19%) ▼|NEE85.54+0.42 (+0.49%) ▲|NFLX60.87-1.28 (-2.06%) ▼|NKE37.82-0.17 (-0.45%) ▼|NOW100.53-1.72 (-1.69%) ▼|NVDA155.25-7.60 (-4.67%) ▼|ORCL118.96-6.39 (-5.10%) ▼|PEP147.69+2.25 (+1.55%) ▲|PFE28.95+0.06 (+0.19%) ▲|PG173.13+3.33 (+1.96%) ▲|PLTR161.10-6.89 (-4.10%) ▼|PM196.43-2.53 (-1.27%) ▼|QCOM170.86-1.61 (-0.93%) ▼|RTX195.70-2.88 (-1.45%) ▼|SBUX108.04+1.60 (+1.50%) ▲|SCHW93.34+0.36 (+0.38%) ▲|SO94.08+1.25 (+1.35%) ▲|SPG231.12-1.85 (-0.79%) ▼|T22.31+0.13 (+0.56%) ▲|TMO695.19-5.03 (-0.72%) ▼|TMUS171.88+1.93 (+1.14%) ▲|TSLA378.61-11.62 (-2.98%) ▼|TXN295.91-7.70 (-2.53%) ▼|UBER69.67-0.02 (-0.03%) ▼|UNH410.10+2.64 (+0.65%) ▲|UNP304.43+1.99 (+0.66%) ▲|UPS111.29+0.53 (+0.48%) ▲|USB60.44-0.55 (-0.90%) ▼|V427.39+1.63 (+0.38%) ▲|VZ46.43+0.07 (+0.15%) ▲|WFC84.38-1.68 (-1.95%) ▼|WMT128.25+0.16 (+0.12%) ▲|XOM167.38-2.14 (-1.26%) ▼|
13 C
New York
Monday, November 16, 2026

Tag: release

Raytech Holding Limited Announces Fiscal Year 2025 Financial Results and the Filing of Its Annual Report on Form 20-F

Revenue Growth of 17.6% to HK$78.7 Million (US$10.1 million); Strong Cash Position of HK$84.9 Million (US$10.9 million)
Revenue Growth of 17.6% to HK$78.7 Million (US$10.1 million); Strong Cash Position of HK$84.9 Million (US$10.9 million)

Cannabis-Induced Psychosis (CIP) Drug Pipeline Market Insights Report 2025 | In-Depth Analysis of CIP Therapeutics – From Early R&D to Market, Covering Collaborations, Licensing,...

Discover the future of Cannabis-Induced Psychosis (CIP) with the latest Pipeline Insight 2025 report. Gain in-depth analysis of CIP therapeutic developments, from early to marketed stages, including collaboration trends, licensing deals, and clinical trials. Navigate key players, active projects, and market growth strategies within the evolving CIP landscape.
Discover the future of Cannabis-Induced Psychosis (CIP) with the latest Pipeline Insight 2025 report. Gain in-depth analysis of CIP therapeutic developments, from early to marketed stages, including collaboration trends, licensing deals, and clinical trials. Navigate key players, active projects, and market growth strategies within the evolving CIP landscape.

Vaisala Corporation: Share Repurchase 25.7.2025

More information:
Niina Ala-Luopa
+358 400 728 957, ir@vaisala.com 

Vaisala Oyj: Omien osakkeiden hankinta 25.7.2025

Lisätietoja:
Niina Ala-Luopa
0400 728 957, ir@vaisala.com 

Five Farms Irish Cream and Holladay Bourbon Bring Spirited Flavor to Tales of the Cocktail 2025 in New Orleans

New Orleans, La., July 25, 2025 (GLOBE NEWSWIRE) -- In a city where every cocktail tells a story, Five Farms Irish Cream and Holladay Bourbon made a memorable mark at Tales of the Cocktail 2025, weaving their distinct heritages into the vibrant fabric of New Orleans' world-famous drinks festival and conference.

BitMart and Altrady Announce New Partnership for Enhanced Trading

Mahe, Seychelles, July 25, 2025 (GLOBE NEWSWIRE) -- BitMart, a leading global cryptocurrency exchange, is thrilled to announce its strategic integration with Altrady, a powerful cryptocurrency trading platform designed to streamline trading across multiple exchanges. This collaboration empowers BitMart users to connect their BitMart Futures accounts to Altrady, offering advanced trading tools, seamless portfolio management, and enhanced efficiency for traders of all levels.

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on Monday, July 28, 2025

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on Monday, July 28, 2025

DebitMyData Closes Oversubscribed Seed Round- Launches $1B Human Energy Grid Global Expansion

Seed raise exceeding 200% of target positions the DebitMyData Digital Identity LLM (DID-LLM) for Global Partnerships and Licensing

Medical Cannabis Market Report 2025-2033 | Rising Clinical Trials, R&D Activities, and Commercialization of Cannabis-based Indications

Global medical cannabis market to hit USD 68.6 billion by 2033, growing at a 7.1% CAGR. Key growth drivers include increasing legalization and therapeutic use for conditions like chronic pain and epilepsy. North America leads due to progressive regulations. Top players like Canopy Growth and GW Pharmaceuticals drive innovation in the sector.
Global medical cannabis market to hit USD 68.6 billion by 2033, growing at a 7.1% CAGR. Key growth drivers include increasing legalization and therapeutic use for conditions like chronic pain and epilepsy. North America leads due to progressive regulations. Top players like Canopy Growth and GW Pharmaceuticals drive innovation in the sector.

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Replimune Group (REPL) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to...

ATLANTA, July 25, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information, including allegations that: (1) Defendants recklessly overstated the IGNYTE trial’s prospects, given material issues that defendants knew or should have known of, which resulted in the FDA deeming the IGNYTE trial inadequate and not well-controlled; and (2) as a result, defendants’ statements about Replimune’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRelease